Insmed
INSM
114 hedge funds and large institutions have $1.03B invested in Insmed in 2015 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 42 increasing their positions, 40 reducing their positions, and 18 closing their positions.
5% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 40
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less capital invested
Capital invested by funds: $1.05B → $1.03B (-$21.1M)
4% less funds holding
Funds holding: 119 → 114 (-5)
23% less call options, than puts
Call options by funds: $5.84M | Put options by funds: $7.62M
28% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$7.82M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$6.76M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$5.72M |
| 4 |
O
OrbiMed
New York
|
+$5.72M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.49M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$18M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
-$10.3M |
| 3 |
State Street
Boston,
Massachusetts
|
-$6.04M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$3.06M |
| 5 |
Citigroup
New York
|
-$2.95M |
INSM Hedge Fund Activity: Q4 2015 in Review
114 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q4 2015, worth a combined $1.03B — down 2% from $1.05B a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of INSM and 13 opened new positions — a net loss of 5 holders — while 40 trimmed existing stakes and 42 added.
The largest buyer was Redmile Group, adding an estimated $7.82M. The largest seller was Citadel Advisors, cutting an estimated $18M.
- 114 institutional investors held Insmed (INSM) as of Q4 2015, down from 119 in Q3 2015.
- Funds reported $1.03B of Insmed stock for Q4 2015, down 2% quarter-over-quarter.
- 13 funds opened new Insmed positions in Q4 2015 and 18 closed out, a net change of -5 holders.
- The largest Insmed buyer in Q4 2015 was Redmile Group, an estimated $7.82M added.
- The largest Insmed seller in Q4 2015 was Citadel Advisors, an estimated $18M sold.
Based on aggregated 13F filings for Q4 2015.